Chemoinformaics analysis of 2-O-Methyl-L-arabinose
Molecular Weight | 164.157 | nRot | 5 |
Heavy Atom Molecular Weight | 152.061 | nRig | 1 |
Exact Molecular Weight | 164.068 | nRing | 0 |
Solubility: LogS | 0.052 | nHRing | 0 |
Solubility: LogP | -1.882 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 22.0315 |
nHD | 3 | BPOL | 14.6425 |
QED | 0.406 |
Synth | 3.9 |
Natural Product Likeliness | 2.052 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.014 |
HIA | 0.306 |
CACO-2 | -5.172 |
MDCK | 0.00211303 |
BBB | 0.156 |
PPB | 0.265286 |
VDSS | 0.435 |
FU | 0.764905 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.084 |
CYP2c19-inh | 0.011 |
CYP2c19-sub | 0.097 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.067 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.117 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.054 |
CL | 3.438 |
T12 | 0.78 |
hERG | 0.077 |
Ames | 0.125 |
ROA | 0.008 |
SkinSen | 0.683 |
Carcinogencity | 0.013 |
EI | 0.858 |
Respiratory | 0.047 |
NR-Aromatase | 0.012 |
Antiviral | No |
Prediction | 0.928511 |